Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

UBS Analyst Maintains Buy Rating on JNJ.US with $320 Target Price

Guavy AI Editorial Team
Instruments
JNJ
Share

UBS analyst Michael Yee has reaffirmed his buy rating for Johnson & Johnson (JNJ.US), maintaining a target price of $320.

This decision comes after evaluating the company's performance and market trends. According to data from TipRanks, Yee has a success rate of 48.7% and an average return of 3.7% over the past year.

TipRanks provides analysis on financial analysts' recommendations and calculates their success rates and average returns. The platform uses virtual portfolios to test these predictions against market performance.

More on Stocks

Stocks just now

American Airlines Unveils Luxurious Boeing 777-300ER Makeover

Stocks 1m ago

Boeing Lands $55M Contract for MH-47G Upgrade

Stocks 1m ago

FAA Fines Boeing Max Penalty Falls Short of Deterrent

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy